FDA approves new painkiller designed to avoid opioid addiction risk
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
Psychology Today14h
Opioid Crisis: Grading the Progress of National Initiatives
Drug experts Drs. Volkow and McLellan set out a road map to reverse the opioid epidemic in 2016. Find out how we're doing now ...
FDA approves Vertex's non-opioid painkiller, first new kind of pain medicine in decades
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...
FDA approves new, non-opioid painkiller Journavx
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
Friday briefing: D.C. plane crash updates; Trump fact check; Tulsi Gabbard and Kash Patel; Ebola; non-opioid painkiller; and more
President Donald Trump baselessly blamed a diversity program for the crash. Meta CEO Mark Zuckerberg said the company is still committed to diversity.
FDA approves new type of nonopioid painkiller for acute pain
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...
Alert: US regulators approve new type of pain drug designed to eliminate the risks of addiction associated with opioids
WASHINGTON (AP) — US regulators approve new type of pain drug designed to eliminate the risks of addiction associated with opioids.
ThePrint3h
North America braces for new Trump tariffs as Saturday deadline nears
Companies, consumers and farmers across North America braced on Friday for U.S. President Donald Trump to impose 25% tariffs ...